Intellipharmaceutics International Inc. Quarterly Liabilities and Equity in CAD from Q4 2015 to Q4 2018

Taxonomy & unit: us-gaap: CAD and USD
Description: Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary: Intellipharmaceutics International Inc. quarterly Liabilities and Equity history and growth rate from Q4 2015 to Q4 2018.
Intellipharmaceutics International Inc. Liabilities and Equity for the quarter ending November 30, 2018 was CA$11.5M, a 55.1% increase year-over-year.

Liabilities and Equity, Quarterly (CAD)

Liabilities and Equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2018	11.5M	+4.08M	+55.1%	Nov 30, 2018	20-F/A	2019-03-04
Q4 2017	7.4M	-578K	-7.25%	Nov 30, 2017	20-F/A	2019-03-04
Q2 2017	7.78M			May 31, 2017	6-K	2017-07-11
Q1 2017	7.96M			Feb 28, 2017	6-K	2017-04-12
Q4 2016	7.97M	+2.75M	+52.6%	Nov 30, 2016	20-F	2018-03-01
Q4 2015	5.22M			Nov 30, 2015	20-F	2017-02-28

* An asterisk sign (*) next to the value indicates that the value is likely invalid.